ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,709.82
      0.11%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      07/30/20206:42PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:QUREuniQure NV
      07/30/20207:05AMGlobeNewswire Inc.uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      07/24/20204:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      06/30/20204:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      06/24/20206:28PMPR Newswire (US)CSL Behring Agrees to Acquire Novel Late-Stage Gene Therapy Candidate for Hemophilia B Patients from uniQureNASDAQ:QUREuniQure NV
      06/24/20204:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      06/24/20204:05PMGlobeNewswire Inc.uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene TherapyNASDAQ:QUREuniQure NV
      06/23/20204:18PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:QUREuniQure NV
      06/22/20204:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      06/19/20207:05AMGlobeNewswire Inc.uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Dise...NASDAQ:QUREuniQure NV
      06/17/20204:05PMGlobeNewswire Inc.uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of DirectorsNASDAQ:QUREuniQure NV
      06/15/20208:32AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:QUREuniQure NV
      06/15/20207:05AMGlobeNewswire Inc.uniQure Announces Change for its 2020 Annual General Meeting of ShareholdersNASDAQ:QUREuniQure NV
      05/22/20205:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      05/14/20204:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      05/14/20207:00AMGlobeNewswire Inc.uniQure Presents New Preclinical Data in SCA3, Fabry Disease, and Hemophilia A at the ASGCT Annual MeetingNASDAQ:QUREuniQure NV
      04/29/20205:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      04/29/20207:00AMGlobeNewswire Inc.uniQure Announces First Quarter 2020 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      04/29/20206:49AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:QUREuniQure NV
      04/29/20206:11AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:QUREuniQure NV
      04/28/20204:51PMGlobeNewswire Inc.uniQure Announces Significant Presence at Upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual MeetingNASDAQ:QUREuniQure NV
      04/28/20204:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      04/24/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      04/17/20205:26PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:QUREuniQure NV
      04/17/20207:00AMGlobeNewswire Inc.uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of DirectorsNASDAQ:QUREuniQure NV
      04/14/202012:48PMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:QUREuniQure NV
      04/14/202012:47PMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:QUREuniQure NV
      03/30/20207:00AMGlobeNewswire Inc.uniQure to Participate in Multiple Upcoming Investor Conferences in AprilNASDAQ:QUREuniQure NV
      03/27/20204:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      03/26/20207:00AMGlobeNewswire Inc.uniQure Announces Achievement of Target Patient Dosing in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Hemo...NASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE